# Molecular Analysis and Treatment Options of Thymic Malignancies

> **NCT05667948** · — · RECRUITING · sponsor: **Shanghai Chest Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Thymic Epithelial Tumor
- Thymic Carcinoma
- Thymic Cancer

## Interventions

- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT05667948
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05667948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05667948, "Molecular Analysis and Treatment Options of Thymic Malignancies". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05667948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*